Technical analysis of Repligen Corporation (RGEN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing.
Price Performance
| 1 month | +13.07% |
| 3 months | +37.91% |
| Year-to-date | +15.65% |
| 1 year | +26.25% |
| 3 years | +23.37% |
| 5 years | -30.37% |
52-Week Range
| 52-week High | $198.87 |
| 52-week Low | $100.99 |
| Avg Volume (90d) | 1.1M |
Technical Indicators
| SMA 50 | $170.82 |
| SMA 200 | $143.66 |
| Beta | 1.19 |
| 30-day Volatility (annualised) | 43.3% |
| Price vs SMA 50 | +10.9% |
| Price vs SMA 200 | +31.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-11 | $171.02 | |
| 2025-12 | $163.86 | -4.2% |
| 2026-01 | $149.37 | -8.8% |
| 2026-02 | $128.73 | -13.8% |
| 2026-03 | $117.82 | -8.5% |
| 2026-04 | $118.31 | +0.4% |
| 2026-05 | $123.95 | +4.8% |
| 2026-06 | $136.44 | +10.1% |
| 2026-07 | $141.01 | +3.3% |
| 2026-08 | $180.98 | +28.3% |
| 2026-09 | $192.23 | +6.2% |
| 2026-10 | $189.50 | -1.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-03 | $0.46 | $207M |
| 2026-07-28 | $0.45 | $202M |
| 2026-05-05 | $0.38 | $192M |
| 2026-02-24 | $0.44 | $193M |
| 2025-10-28 | $0.42 | $182M |
| 2025-07-29 | $0.40 | $175M |
| 2025-04-29 | $0.35 | $164M |
Price
| Price | $189.50 |
| Market Cap | $10.7B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 256.08 |
| Price / Book | 5.06 |
| EV / EBITDA | 88.47 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.33 |
| Current Ratio | 9.05 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 7.49 |